DOI QR코드

DOI QR Code

Chemical Pleurodesis Using a Viscum album Extract in an Infant with Postoperative Chylothorax: A Case Report

  • Yun, Taeyoung (Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine) ;
  • Kwon, Hye Won (Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine) ;
  • Park, Samina (Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine) ;
  • Kim, Woong-Han (Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine)
  • Received : 2021.08.12
  • Accepted : 2021.11.06
  • Published : 2022.02.05

Abstract

Chylothorax after thoracic surgery is a rare complication, and treatment for refractory chylothorax is challenging. We report a case of chylothorax after cardiothoracic surgery in an infant after failure of conservative management and thoracic duct ligation. The patient underwent chemical pleurodesis with a Viscum album extract. The treatment was successful and chylothorax did not recur.

Keywords

References

  1. Mery CM, Moffett BS, Khan MS, et al. Incidence and treatment of chylothorax after cardiac surgery in children: analysis of a large multi-institution database. J Thorac Cardiovasc Surg 2014;147:678-86. https://doi.org/10.1016/j.jtcvs.2013.09.068
  2. Biewer ES, Zurn C, Arnold R, et al. Chylothorax after surgery on congenital heart disease in newborns and infants: risk factors and efficacy of MCT-diet. J Cardiothorac Surg 2010;5:127. https://doi.org/10.1186/1749-8090-5-127
  3. Costa KM, Saxena AK. Surgical chylothorax in neonates: management and outcomes. World J Pediatr 2018;14:110-5. https://doi.org/10.1007/s12519-018-0134-x
  4. Aljazairi AS, Bhuiyan TA, Alwadai AH, Almehizia RA. Octreotide use in post-cardiac surgery chylothorax: a 12-year perspective. Asian Cardiovasc Thorac Ann 2017;25:6-12. https://doi.org/10.1177/0218492316682670
  5. Rosti L, De Battisti F, Butera G, et al. Octreotide in the management of postoperative chylothorax. Pediatr Cardiol 2005;26:440-3. https://doi.org/10.1007/s00246-004-0820-4
  6. Schild HH, Naehle CP, Wilhelm KE, et al. Lymphatic interventions for treatment of chylothorax. Rofo 2015;187:584-8. https://doi.org/10.1055/s-0034-1399438
  7. Mierzejewski M, Korczynski P, Krenke R, Janssen JP. Chemical pleurodesis: a review of mechanisms involved in pleural space obliteration. Respir Res 2019;20:247. https://doi.org/10.1186/s12931-019-1204-x
  8. Kienle GS, Kiene H. Review article: influence of Viscum album L (European mistletoe) extracts on quality of life in cancer patients: a systematic review of controlled clinical studies. Integr Cancer Ther 2010;9:142-57. https://doi.org/10.1177/1534735410369673
  9. Lee YG, Jung I, Koo DH, et al. Efficacy and safety of Viscum album extract (Helixor-M) to treat malignant pleural effusion in patients with lung cancer. Support Care Cancer 2019;27:1945-9. https://doi.org/10.1007/s00520-018-4455-z
  10. Cho HJ, Na KJ, Kim DW, Choi YE, Ma JS, Jeong IS. Chemical pleurodesis using a Viscum album extract in infants with congenital chylothorax. Eur J Pediatr 2014;173:823-6. https://doi.org/10.1007/s00431-014-2283-9